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Effects of a Myrciaria jaboticaba peel extract on
starch and triglyceride absorption and the role of
cyanidin-3-O-glucoside
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Maria Inês Dias, c Isabel C. F. R. Ferreira, c Jurandir Fernando Comar,b
Tamires Barlati Vieira da Silva,a Rosane Marina Peralta,b
Anacharis Babeto de Sá-Nakanishib and Adelar Bracht *b
The purpose of this study was to perform a parallel and comparative investigation of the effects of a
Myrciaria jaboticaba (common name jabuticaba) peel extract and of its constituent cyanidin-3-O-gluco-
side on the overall process of starch and triglyceride intestinal absorption. The peel extract inhibited both
the porcine pancreactic α-amylase and the pancreatic lipase but was 13.6 times more potent on the latter
(IC50 values of 1963 and 143.9 μg mL−1, respectively). Cyanidin-3-O-glucoside did not contribute signifi-
cantly to these inhibitions. The jabuticaba peel extract inhibited starch absorption in mice at doses that
were compatible with its inhibitory action on the α-amylase. No inhibition of starch absorption was found
with cyanidin-3-O-glucoside doses compatible with its content in the extract. The extract also inhibited
triglyceride absorption, but at doses that were considerably smaller than those predicted by its strength in
inhibiting the pancreatic lipase (ID50 = 3.65 mg kg
−1). In this case, cyanidin-3-O-glucoside was also
strongly inhibitory, with 72% inhibition at the dose of 2 mg kg−1. When oleate + glycerol were given to
mice, both the peel extract and cyanidin-3-O-glucoside strongly inhibited the appearance of triglycerides
in the plasma. The main mechanism seems, thus, not to be the lipase inhibition but rather the inhibition
of one or more steps (e.g., transport) in the events that lead to the transformation of free fatty acids in the
intestinal tract into triglycerides. Due to the low active doses, the jabuticaba peel extract presents many
favourable perspectives as an inhibitor of fat absorption and cyanidin-3-O-glucoside seems to play a
decisive role.
Introduction
Myrciaria jaboticaba, belonging to the Myrtaceae family, is a
fructiferous plant from Brazil, extensively cultivated mainly in
the southeastern part of the country. The fruits, known as
jabuticaba, are globular with a thick skin and juicy pulp, and
are generally sweet.1 They present a high content in phenolics,
anthocyanins, ellagic acid, and a pronounced antioxidant
capacity in vitro.2 Jabuticaba possesses a high commercial
potential thanks to its pleasant sensorial properties in
addition to its nutritional and functional properties.3 Its popu-
larity has been compared to that of the berries in North
America. Due to its sweet and characteristic taste the pulp of
jabuticaba has been consumed either in natura or used in the
production of jams, wines, liqueurs and juices. The jabuticaba
skin, on the other hand, is rigid and has an astringent taste. It
is usually discarded as residue by the food industry, but it is
also a potential source of bioactive molecules and a functional
food.2,4 In a recent study, several phenolic compounds have
been identified in a hydroalcoholic extract of the skins
among anthocyanins (e.g., cyanidin-3-O-glucoside) and non-
anthocyanins.5
There are several reports attributing metabolic effects to
extracts or chemical components of both the jabuticaba whole
fruit and skin. For example, the daily intake during 40 days of
1 to 2 g kg−1 of a dried hydroalcoholic extract of the whole
fruit by diabetic rats caused substantial diminution in the
levels of total cholesterol and triacylglycerols in the plasma
and a reduction in post-prandial glycemia.6 These effects were
attributed, partly at least, to the inhibition of the pancreatic
lipase by the extract. The IC50 of the total fruit extract for this
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inhibition, however, was very high, namely 1080 μg mL−1 of
the reaction medium, a point to be taken into account in
terms of future clinical applications.6 In line with an effect on
lipid metabolism is the report of experiments in which the
dried jabuticaba peel was fed to rats and which resulted in
increased excretion of fecal triglycerides.7 In another study in
which obese rodents were fed with diets containing fractions
of dried skin, increased HDL cholesterol and diminished
insulin levels were found.8 Cyanidin-3-O-glucoside, the main
anthocyanin of the skin,5 has also been frequently associated
with lipid metabolism. Food supplementation with cyanidin-3-
O-glucoside to obese mice reduced body weight, visceral
adiposity, hepatic steatosis and plasma levels of
triacylglycerols.9–11 It also reduced hyperglycemia and
improved sensitivity to insulin in diabetic mice.12 Many of
these effects have been attributed to the ability of cyanidin-3-
O-glucoside in modulating the activity of the lipoprotein lipase
in tissues and in increasing the activity of the brown adipose
tissue.9,10
The observations that were summarized above strongly indi-
cate that jabuticaba extracts and its constituent cyanidin-3-O-
glucoside affect lipid and possibly also carbohydrate metab-
olism. The most striking possibility is an action on triglyceride
and possibly also on starch absorption from the intestinal
tract. Close examination of the reports, however, reveal that a
direct proof that these events really occur in vivo is still
lacking. Furthermore, mechanistic details of the action of
jabuticaba extracts and of their main constituent cyanidin-3-O-
glucoside are still to be elucidated. For this reason, we decided
to investigate in detail these actions in mice by administering
defined doses of an hydroalcoholic extract of jabuticaba peel
and cyanidin-3-O-glucoside and by measuring their actions on
triglyceride and starch absorption. An hydroalcoholic peel
extract was used instead of a total fruit extract for two main
reasons. The first reason is that most studies on the biological
effects of the jabuticaba have been conducted using peel
extracts. The second one is that cyanidin-3-O-glucoside, a com-
pound that is of particular interest for the present study,
seems to be fairly abundant in the skin.5 If this commercially
available compound participates in a significant way in the
effects of jabuticaba extracts, the study may open the way for




Porcine pancreatic α-amylase (type IV-B), pancreatic lipase
(type II) and potato starch were purchased from Sigma-Aldrich.
Cyanidin-3-O-glucoside hydrochloride (C3G, 98% pure) was
purchased from Biopurify Phytochemicals Ltd (Chengdu,
China). Phenolic compound standards (ellagic acid, quercetin-
3-O-glucoside and cyanidin-3-O-glucoside) were purchased
from Extrasynthese (Genay, France). Excipient-free acarbose
and orlistat were obtained from Manipulação Farmácias São
Paulo (Maringá, Brazil). Origin of both products is Fagron SM
(Waregem, Belgium). All reagent grade chemicals were from
the highest possible degree of purity.
Preparation of hydroethanolic extract of M. jaboticaba peels
The jabuticaba skins (peels) were purchased from the Belo
Farm (São Paulo State, Brazil). They were dried in a recirculation
oven at 45 °C and ground to a fine powder. This powder was
suspended in a 70% hydroalcoholic solution at a proportion of
10 g powder per 100 mL extraction solution. The mixture was
kept on a rotary shaker (120 rpm) for 2 hours at room tempera-
ture and protected from light. Agitation was followed by fil-
tration through Whatman 1 and the filtrate was collected. The
solid residue was submitted to two additional and successive
extractions. The combined filtrates were concentrated in an
oven at 45 °C for ethanol evaporation. The aqueous solution
was finally lyophilized and stored in freezer at −20 °C.
Determination of the phenolic profile of the hydroethanolic
extract of the M. jaboticaba peels
For determining the phenolic profile of the sample, the lyophi-
lized extract (10 mg) was re-dissolved in 2 mL of ethanol : water
(70 : 30 v/v) and filtered through a 0.22 µm disposable filter
disk into an amber vial for HPLC analysis.
Non-anthocyanin and anthocyanin compounds were deter-
mined by high-performance liquid chromatography (Dionex
Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA, USA),
with diode-array detector (280, 330, and 370 nm wavelengths
for non-anthocyanin compounds, and 520 nm wavelength for
anthocyanin compounds) linked to an electrospray ionization
mass spectrometer working in negative mode (non-anthocya-
nin compounds) and positive mode (anthocyanin compounds)
(Linear Ion Trap LTQ XL, Thermo Scientific, San Jose, CA,
USA) under conditions previously described.13 Phenolic com-
pounds were identified comparing their UV-vis and MS reten-
tion times with those obtained from available standards and
data from our compound library and the literature. The results
were expressed in mg g−1 extract.
Animals
The present work was approved by the Ethics Committee on
the Use of Animals in Experimentation (CEUA) of the State
University of Maringá (protocol number 9577260819). Male
Swiss mice weighing between 35 and 40 g were used (age of
approximately 40 days). The mice were fed with standard chow
diet and received water ad libitum. Three animals were kept in
each cage according to the universally accepted guidelines for
animal experimentation.
Pancreatic α-amylase assay and kinetics
The activity of the porcine pancreatic α-amylase (initial reaction
rate) was measured as the rate of reducing sugar formation.14
The reaction medium was 20 mM phosphate buffer, pH 6.9,
containing 6.7 mM NaCl.15,16 Substrate (starch), enzyme and
inhibitors ( jabuticaba peel extract or cyanidin-3-O-glucoside
hydrochloride) were all dissolved into this medium. The volume
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of the final reaction medium was equal to 1.0 mL and was com-
posed of 500 μL substrate solution, 250 μL inhibitor solution
and 250 μL enzyme solution. The final concentrations of starch
were in the range between 0.05 and 1 g per 100 mL, those of the
M. jaboticaba peel extract in the range between 20 and 4000 μg
mL−1 and those of cyanidin-3-O-glucoside in the range between
5 and 160 μg mL−1. The enzyme concentration in all incu-
bations was equal to 0.75 units per mL under the conditions of
the assay. Initially reaction medium and the substrate solution
were mixed and incubated for 5 minutes at 37 °C. This was fol-
lowed by the addition of the enzyme solution. After 10 minutes
incubation at 37 °C the reaction was stopped by keeping the
reaction tube in boiling water for 5 minutes. The reducing
sugars were determined by the 3,5-dinitrosalicylate method,
using maltose as standard.14 Absorbance, which is directly pro-
portional to the concentration of reducing sugars, was read at
540 nm. Interference by the components of the extract or cyani-
din-3-O-glucoside with the absorbance measurements was
monitored by parallel incubations containing the same inhibi-
tor concentrations and buffer solution in place of the enzyme.
To these incubations samples 3,5-dinitrosalicylate was added
and their absorbance subtracted from the absorbance of the
incubations containing the enzyme. The reaction rates were
expressed as μmol per minute.
Pancreatic lipase assay and kinetics
The activity of the pancreatic lipase (initial reaction rate) was
measured using p-nitrophenyl-palmitate as substrate.17 The
latter was suspended in isopropanol and the suspension was
sonicated until complete solubilization. The enzyme (porcine
pancreatic lipase) was initially suspended in Tris-HCl buffer at
the concentration of 2 mg mL−1. This suspension was centri-
fuged (2000g, 5 min) and the supernatant used as the enzyme
source. The reaction medium was 10 mM Tris-HCl buffer (pH
8.2) containing p-nitrophenyl-palmitate at various concen-
trations in the range up to 530 μM, according to the experi-
mental protocol. The M. jabuticaba peel extract was added for
final concentrations of up to 300 μg mL−1, according to the
experimental protocol. Cyanidin-3-O-glucoside was added for
final concentrations of up to 200 mg mL−1. The incubation
temperature was 37 °C. After 5 minutes the reaction was
started by adding an aliquot of the enzyme solution (0.1 mL).
The reaction was stopped after 10 minutes by keeping the reac-
tion tube in boiling water for 5 minutes. After cooling at room
temperature, the reaction tube was centrifuged (21 000g for
10 min) and the absorbance of the supernatant, due to the
released p-nitrophenol, was determined at 410 nm against a
blank containing the denatured enzyme. Interference by the
components of the extract or cyanidin-3-O-glucoside with the
absorbance measurements was monitored by parallel incu-
bations containing the same inhibitor concentrations and
buffer solution in place of the enzyme. The absorbance of
these samples was subtracted from the absorbance of the incu-
bations containing the enzyme. The reaction rate was
expressed as μmol per minute using the extinction coefficient
of 1.83 × 104 M−1 cm−1.
Starch tolerance test in mice
Fasted mice (18 hours) were used and the administration route
was in all cases intragastric (by gavage). The number of
animals for each experimental approach was between 5 and 7.
Positive controls received commercial corn starch (1 g per kg
body weight) and negative controls filtered tap water.16 The
M. jaboticaba extract was administered at the doses of 250 or
500 mg kg−1 to two different groups of mice in addition to
commercial corn starch. Cyanidin-3-O-glucoside was given at
the doses of 10 mg kg−1 or 20 mg kg−1 to two different groups
of mice in addition to commercial corn starch. Finally, experi-
ments were also done with the reference substance acarbose
which was given to the mice at the dose of 50 mg kg−1 in
addition to commercial corn starch. Plasma glucose was deter-
mined at times 0, 30, 60, 90 and 120 minutes after starch
administration. Blood samples were collected from the tail
vein and analyzed by means of a glucometer (AccuChek®).
Glucose tolerance test in mice
Glucose tolerance was assayed in order to find out if the
M. jaboticaba extract interferes with glucose transport across
the enterocytes (intestinal cells). Fasted mice were used after a
fasting period of 18 h. Two different doses of M. jaboticaba
extract were administered to different groups of animals,
250 mg kg−1 and 500 mg kg−1. Controls received just filtered
tap water. Glucose was administered intragastrically to all
animals (1.5 g kg−1). Blood samples were collected from the
tail vein at times 0, 30, 60, 90 e 120 minutes and analyzed by
means of a glucometer (AccuChek®).
Triglyceride tolerance test in mice
Intestinal triglyceride absorption was evaluated by means of
the tolerance to olive oil after 18 hours fasting.17 The
M. jaboticaba extract was solubilized in filtered water and the
following doses were administered intragastrically to different
groups of animals: 1, 5, 25 and 250 mg per kg of body weight;
the controls received filtered water in place of the extract solu-
tion. Cyanidin-3-O-glucoside was equally solubilized in filtered
tap water and given intragastrically to two different groups of
animals at the doses of 0.2 and 2 mg per kg body weight; here
again the controls received filtered water in place of the cyani-
din-3-O-glucoside solution. The reference substance orlistat
was given to a separate group of animals at the dose of 50 mg
kg−1. After drug administration all animals received intragas-
trically olive oil (5 mL per kg body weight). The plasma trigly-
ceride levels were determined at 0, 1.5, 3.0, 4.5 and 6.0 hours
in blood samples collected from the tail vein. For each experi-
mental procedure 3 to 4 animals were used.
Measurement of blood triglycerides was carried out by
means of an AccutrendPlus® Roche triglyceride meter. The
choice of this method was based on the advantage that only
drops of blood are needed. Such small samples can be easily
obtained from the tail vein of the mice. The method of assay
of the AccutrendPlus® Roche triglyceride meter is an end-
point enzymatic-colorimetric assay, which actually measures
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the glycerol moiety of the triglycerides. As such it suffers a
small interference by free glycerol, which is generally accepted
as tolerable for clinical purposes.18 It was shown that the
AccutrendPlus® Roche triglyceride meter measures with
almost equal precision both VLDL and chylomicron triglycer-
ides. Comparison with a conventional enzymatic method
revealed a mean difference of 0.94% between both methods.18
Triglycerides in plasma after oleate administration to mice
The animals were deprived of food for 18 hours prior to the
experiments. Solutions (100 μL) of the M. jaboticaba peel extract
and cyanidin-3-O-glucoside were administered orally at the
doses of 5 and 25 mg kg−1 and 0.2 and 2 mg kg−1, respectively.
Controls received tap water (200 μL). Oleic acid (180 μL) plus gly-
cerol (20 μL) were administered orally to all animals. Additional
controls were done by administering separately glycerol (20 μL)
or oleic acid (180 μL). Blood samples from the tail vein were
analyzed with the AccutrendPlus® Roche triglyceride meter as
described in the preceding item at zero time ( just before gly-
cerol and oleate administration) and after 90 minutes.
Calculations and statistical criteria
Numerical interpolation for the determination of the half-
maximal inhibitor concentrations (EC50) was done using the
Scientist software from MicroMath Scientific Software (Salt
Lake City, UT). The same program was used for fitting the rate
equations to the experimental initial rates of enzymatic activity
by means of an iterative non-linear least-squares procedure.
The decision about the most adequate model (equation) was
based on the model selection criterion (MSC) and on the stan-
dard deviations of the optimized parameters. The model selec-
tion criterion, which corresponds to the normalized Akaike












Yobs are the experimental reaction rates, Ȳobs the mean
experimental reaction rate, Ycal the theoretically calculated
reaction rate, w the weight of each experimental point, n the
number of observations and p the number of parameters of
the set of equations. In the present work, the model with the
largest MSC value was considered the most appropriate, pro-
vided that the estimated parameters were positive. When the
MSC values differed by less than 5%, the mode yielding the
smallest standard deviations for the estimated parameters was
considered the most appropriate one.
Results
Phenolic profile of the hydroethanolic extract of M. jaboticaba
peels
Previous to the biological assays, the phenolic profile of the
M. jaboticaba peel extract was determined. Table 1 presents
chromatographic parameters, spectral data and contents.
Phenolic compounds were identified according to the chroma-
tographic characteristics, ultraviolet light absorption and mass
spectra, as previously described in the literature for jabuticaba
residues.5,13 The phenolic profile of the jabuticaba peels extract
used in the present work includes twelve compounds, ten non-
anthocyanin compounds and two anthocyanins. Among non-
anthocyanin compounds, ellagic acid derivatives (peaks 1–9)
were most abundant, and a quercetin derivative, namely querci-
trin (peak 10), was also found. The anthocyanin compounds
detected were a delphinidin-3-O-glucoside and a cyanidin-3-O-
glucoside (peaks 11 and 12, respectively), the latter being the
most representative, as already described in the literature.5,13
Effects of the jabuticaba peel extract and cyanidin-3-O-
glucoside on α-amylase
The possible action of the jabuticaba peel extract on the pan-
creatic α-amylase was investigated based on reports that similar
preparations may influence blood glucose levels. Inhibition of
the pancreatic α-amylase is a possible mechanism. The results
of the first experiments are shown in Fig. 1. The extract in fact
inhibited the pancreatic α-amylase with a well-defined concen-
tration dependence. Inhibition, however, occurred at relatively
high concentrations. This is reflected by the IC50 value, which
numerical interpolation revealed to be equal to 1963 μg mL−1.
When the reciprocal reaction rates (1/v) were plotted against the
extract concentrations, the relationship turned out to be para-
bolic, an observation that predicts the presence of quadratic (or
higher order) inhibitor concentration terms in the steady-state
rate equation (parabolic inhibition).
The next question that can be formulated is one about the
possible contribution of cyanidin-3-O-glucoside to the inhibi-
tory effects of the jabuticaba peel extract on the α-amylase
activity. The experiments that were done in order to find an
answer to this question are shown in Fig. 2. Concentrations of
up to 330 μM cyanidin-3-O-glucoside were investigated (160 μg
mL−1). This highest concentration caused 13.3% inhibition.
For the extract concentration that caused 50% inhibition,
1963 μg mL−1, the fraction corresponding to cyanidin-3-O-glu-
coside was equal to 24.2 μg mL−1 (50 μM) according to Table 1.
The total concentration of the non-anthocyanidin polypheno-
lics for this extract concentration, on the other hand, was
equal to 55.9 μg mL−1 (59.9 μM).
Fig. 3 shows the results that were obtained when starch
(substrate) and extract (inhibitor) concentrations were varied
simultaneously. The usual saturation curve in the absence of
inhibitor was progressively lowered when the extract concen-
tration was raised. The curves present no tendency of conver-
ging at high substrate concentrations, excluding, thus, com-
petitive inhibition. In the search for the most adequate model
that would be able to describe the curves in Fig. 3, the best fit
was obtained with eqn (2):
v ¼ Vmax½S




þ ½S 1þ ½I
Ki2
  ð2Þ
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This equation describes a mechanism in which inhibition
is brought about by the formation of EI, EI2 and ESI com-
plexes, Ki1, K′i1 and Ki2 being the corresponding dissociation
constants.15,16 The EI2 complex is responsible for the parabolic
nature of the inhibition, as revealed by the non-linear relation-
ship between 1/v and [I]. The continuous lines in Fig. 3 were
calculated with the optimized parameters obtained in the
fitting procedure. It should be noted that eqn (2) was fitted
simultaneously to the whole data set, allowing the obtainment
of the whole set of parameters.
Effects of the extract and cyanidin-3-O-glucoside on the
pancreatic lipase
Inhibition of the pancreatic lipase by a whole jabuticaba fruit
extract was previously observed.6 The experiments in this
work were done in order to confirm this effect for the peel
extract and also for evaluating its strength and possible
mechanistic details. The concentration dependence of the
inhibition is shown in Fig. 4. The extract clearly inhibited the
enzyme in a concentration-dependent manner; 50% inhi-
bition, evaluated by numerical interpolation, can be expected
at the extract concentration of 143.9 μg mL−1. The skin extract
is, thus, 7.5 times more potent than the total fruit extract,
whose IC50 value was reported to be 1080 μg mL−1.6 It is also
a much more potent inhibitor of the pancreatic lipase than of
the pancreatic α-amylase, actually 13.6-fold stronger. Plotting
of the inverse of the reaction rates (1/v) against the concen-
trations (Fig. 4) resulted in a parabola, denoting multiple
binding of the inhibitor or inhibitors to the enzyme.
Similarly to what was done with the α-amylase, the effects
of cyanidin-3-O-glucoside on the pancreatic lipase were also
measured. The results are shown in Fig. 5. The concentration
of cyanidin-3-O-glucoside was varied in the range of up to
200 μg mL−1, which in molar terms corresponds to a concen-
tration of 412.5 μM. The compound can be considered a
weak inhibitor of the pancreatic lipase. Even at the highest
concentration, 412.5 μM, inhibition reached only 25%.
Cyanidin-3-O-glucoside in the extract is clearly not the main
responsible for the inhibitory effect of the preparation. The
Fig. 1 Concentration dependences of the inhibition caused by the
Myrciaria jaboticaba peel extract on the porcine α-amylase. Each datum
point is the mean of four determinations. Standard errors of the mean
cannot be seen when smaller than the symbols. Reaction rates (v) and
reciprocals of the reaction rates (1/v) were represented versus the inhibi-
tor concentrations.











1 4.36 244/265 783 481 (54), 301 (100) Bis-HHDP-glucose isomer 14 and 22 2.85 ± 0.05
2 6.14 234/276 935 917 (48), 783 (11), 633 (100), 301 (5) Galloyl-bis-HHDP-glucose isomer 14 2.8 ± 0.2
3 6.91 234/276 935 917 (53), 783 (9), 633 (100), 301 (5) Galloyl-bis-HHDP-glucose isomer 14 3.87 ± 0.07
4 9.95 223/275 785 633 (24), 483 (100), 301 (38) Digalloyl-HHDP-glucose isomer 14 4.1 ± 0.2
5 12.29 229/270 933 915 (13), 633 (26), 451 (100), 301 (12) Castalagin/vescalagin 14 2.22 ± 0.06
6 14.77 234/276 935 917 (60), 783 (10), 633 (100), 301 (7) Galloyl-bis-HHDP-glucose isomer 14 4.87 ± 0.06
7 15.97 220/275 939 787 (13), 769 (100), 301 (3) Pentagalloyl glucose 14 and 22 3.48 ± 0.06
8 16.6 220/275 939 787 (18), 769 (100), 301 (5) Pentagalloyl glucose 14 and 22 2.51 ± 0.06
9 18.15 220/253 301 257 (50), 229 (23) Ellagic acid 22 1.58 ± 0.02
10 21.54 349 447 301 (100) Quercetin-3-O-rhamnoside (quercitrin) 14 and 22 0.218 ± 0.002
TEAD 28.3 ± 0.5
TF 0.218 ± 0.002
TPC non-anthocyanin 28.5 ± 0.5
Anthocyanin compounds
11 15.8 523 463 303 (100) Delphinidin-3-O-glucoside 14 and 22 1.63 ± 0.01
12 21.7 515 449 287 (100) Cyanidin-3-O-glucoside 14 and 22 12.34 ± 0.05
TA 13.97 ± 0.06
RT: retention time; TEAD: total ellagic acid derivatives; TF: total flavonols; TPC: total phenolic compounds; TA: total anthocyanins; HDDP:
hexahydroxydiphenoyl. Phenolic compounds used for quantification: ellagic acid (y = 26719x − 317 255. R2 = 0.9989); quercetin-3-O-glucoside (y =
34 843x − 160 173. R2 = 0.9998); and cyanidin-3-O-glucoside (y = 97787x − 743 469. R2 = 0.9993).
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extract concentration that caused 50% inhibition at a concen-
tration of 143.9 μg mL−1 contains 1.77 μg mL−1 cyanidin-
3-O-glucoside and 4.1 μg mL−1 total non-anthocyanin
polyphenolics.
The effects of the jabuticaba peel extract on the substrate
saturation curves of the porcine pancreatic lipase are shown
in Fig. 6. Similar experiments were not done with cyanidin-
3-O-glucoside because this compound, by being a weak
inhibitor, would need concentrations far above its solubility
limits. As shown in a previous work, the enzyme shows a
substrate-inhibition phenomenon at high p-nitrophenyl pal-
mitate concentrations.17 The position of the curves obtained
in the presence of the jabuticaba skin extract are consistent
with the inhibition already demonstrated in Fig. 4. They do
not present any tendency of converging with the control
curve, suggesting a priori that the inhibition is not of the
competitive type. Attempts at fitting a steady-state equation
to the whole data set took into account this fact and also
the previous observation that inhibition is probably of the












Fig. 2 Concentration dependence of the inhibition caused by cyanidin-
3-O-glucoside on the porcine pancreatic α-amylase. Each datum point
is the mean of three determinations. Standard errors of the mean
cannot be seen when smaller than the symbols. The continuous line was
calculated from the relation y = 0.634 − 0.000262x (r = 0.92; x corres-
ponds to the μM concentration), obtained by fitting the equation
describing the straight line to the data by means of a least squares
procedure.
Fig. 3 Reaction rates of the porcine pancreatic α-amylase obtained by
varying simultaneously the concentrations of the substrate ([S]; starch)
and the Myrciaria jaboticaba peel extract. Each datum point is the mean
of four determinations. The lines running through the experimental
points were calculated using optimized parameters obtained by fitting
eqn (2) to the experimental data by means of a nonlinear least-squares
procedure. Values of the optimized parameters and goodness of fit indi-
cators are: KM, 0.233 ± 0.025 g per 100 mL; Vmax, 0.745 ± 0.027 μmol
min−1; Ki1, 4109.4 ± 3854.7 μg mL−1; K’i1 543.9 ± 0.594 μg mL−1; Ki2,
2470.1 ± 441.0 μg mL−1; sum of squared deviations, 0.00744; MSC,
4.237; correlation, 0.994.
Fig. 4 Concentration dependences of the inhibition caused by the
Myrciaria jaboticaba peel extract on the porcine pancreatic lipase. Each
datum point is the mean of four determinations. Standard errors of the
mean cannot be seen when smaller than the symbols. Reaction rates (v)
and reciprocals of the reaction rates (1/v) were represented versus the
inhibitor concentrations.
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Eqn (3) represents a mechanism of mixed inhibition by the
jabuticaba skin extract with formation of the complexes EI and
ESI2. Vmax and KM represent the maximal reaction rate and the
Michaelis–Menten constant, respectively.17 KiS is the substrate
inhibition constant and Ki1 and K̄i2 are the inhibition con-
stants. Fitting was unsuccessful when a quadratic term of [I]
was omitted. The continuous lines running through the experi-
mental points in Fig. 6 were calculated using eqn (3) with the
optimized parameters obtained in the least-squares fitting pro-
cedure. Values of the optimized parameters are listed in the
legend to Fig. 6. The inhibition constant Ki1 refers to the dis-
sociation of the EI complex. Its value (33.3 μg mL−1) is much
smaller than that of the dissociation constant of the ESI2,
complex, which is K̄i2 (171.3 μg mL−1). This means that, at low
concentrations, inhibition is mainly caused by binding to the
free enzyme.
Effects on starch absorption
Inhibition of starch absorption by jabuticaba formulations
has equally been suggested and can actually be expected
based on the inhibitory effects on the α-amylase shown in
Fig. 1. Our approach to this question is shown in Fig. 7.
After starch administration to mice (1 g kg−1), blood glucose
concentrations were monitored for up to 120 minutes. The
control curve showed the usual rise in blood glucose with
maximal values between 40 and 60 minutes.15 Low doses in
the range of up to 25 mg kg−1 did not affect starch absorp-
tion (not shown). When much higher doses were adminis-
tered, however, a clear inhibitory effect was found, as shown
in Fig. 7(A). The 500 mg kg−1 dose attenuated the concen-
tration versus time curve in a way that is not very far from
the attenuation caused by 50 mg kg−1 acarbose, the classical
inhibitor of starch absorption. Fig. 7(B) allows to compare
the areas under the curves subtracted from the area under
the curve when water was given in place of starch. The jabuti-
caba peel extract doses of 250 and 500 mg kg−1 reduced the
area under the curves by 51 and 84%, respectively. These
extract doses contained 3.2 and 6.1 mg kg−1 cyanidin-3-O-glu-
coside, respectively, and 7.12 and 14.25 mg kg−1 total non-
anthocyanin polyphenolics.
Even though cyanidin-3-O-glucoside is a weak inhibitor
of the α-amylase, effects on other hydrolytic enzymes
(α-glucosidase) and steps of the intestinal glucose absorption
process cannot be excluded. This justifies the experiments
shown in Fig. 8, in which starch was given to mice in
addition to 10 and 20 mg kg−1 cyanidin-3-O-glucoside. These
two doses of pure cyanidin-3-O-glucoside are higher than
those contained in the 250 and 500 mg kg−1 peel extract
doses of the experiment shown in Fig. 7. Hence, if the com-
Fig. 5 Concentration dependence of the inhibition caused by cyanidin-
3-O-glucoside on the porcine pancreatic lipase. Each datum point is the
mean of three determinations. Standard errors of the mean cannot be
seen when smaller than the symbols. The continuous line was calculated
from the relation y = 0.916 − 0.000531x (r = 0.91; x corresponds to the
μM concentration), obtained by fitting the equation describing the
straight line to the data by means of a least squares procedure.
Fig. 6 Reaction rates of the porcine pancreatic lipase obtained by
varying simultaneously the concentrations of the substrate ([S]; p-nitro-
phenyl palmitate) and of the Myrciaria jaboticaba peel extract. Each
datum point is the mean of four determinations. The lines running
through the experimental points were calculated using optimized para-
meters obtained by fitting eqn (3) to the experimental data by means of
a nonlinear least-squares procedure. Values of the optimized para-
meters and goodness of fit indicators are: KM, 69.4 ± 14.7 μM; Vmax, 1.31
± 0.16 μmol min−1; Ki1, 33.3 ± 4.0 μg mL−1; K̄i2, 171.3 ± 76.7 μg mL−1; KiS
= 481.9 ± 159.5 μM; sum of squared deviations, 0.01132; MSC, 4.702;
correlation, 0.997.
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pound gives a significant contribution to the effects of the
extract, this should be detectable. Apparently, cyanidin-3-O-
glucoside, at the doses that were given, does not inhibit
starch absorption, an observation that is consistent with its
weak inhibitory activity on α-amylase. Actually, there is even
a tendency toward higher glycemic levels after 90 minutes,
especially with the 20 mg kg−1 dose. Statistical significance
is lacking, however.
Starch hydrolysis is essential but not the phenomenon
that immediately precedes glucose entry into the systemic
circulation. The released glucose reaches the circulation
after transport across the cell membranes of the cells lining
the intestinal lumen. The glucose tolerance experiments
shown in Fig. 9 were done as an additional control in order
to find out if the jabuticaba peel extract is able to inhibit
absorption of free glucose. The results revealed that at least
the 250 and 500 mg kg−1 doses did not modify the
response of the mice after an intragastric glucose load.
Inhibition of glucose transport across the enterocyte is,
thus, unlikely.
Effects on triglyceride absorption
The question if the jabuticaba peel extract interferes with tri-
glyceride absorption was approached by administering olive
oil to mice and by subsequently following the plasma concen-
tration of triglycerides. It is well established that the absorp-
tion of triglycerides in the intestine depends on the activity of
the pancreatic lipase, which splits these molecules into pro-
ducts that are de facto absorbed and which are in a subsequent
stage used to restore the triglycerides that appear in the
plasma.20 Fig. 10(A) illustrates the time course of the changes
in plasma triglycerides concentrations following the adminis-
tration of olive oil (5 mL kg−1) under various conditions. The
sole administration of olive oil (control curve) was followed by
a clear rise in the plasma concentration of triglycerides with a
Fig. 7 (A) Blood glucose concentration profiles after intragastric starch loads in mice: the effect of the M. jaboticaba residues extract. The oral
administration of commercial starch (1 g per kg body weight) was done immediately after the administration of the extracts or acarbose. The doses
and their estimated contents in cyanidin-3-O-glucoside are given on the graphs. Plasma glucose was measured as described in Materials and
methods. Each value represents the mean ± mean standard error of 4 mice. (B) Areas under the curves obtained after the various treatments with of
M. jaboticaba extract illustrated by panel (A) subtracted from the area under the curve obtained after water administration. Asterisks indicate statisti-
cal significance relative to the control curve (p ≤ 0.05).
Fig. 8 Blood glucose concentration profiles after intragastric starch
loads in mice: the effect of cyanidin-3-O-glucoside administration. The
oral administration of commercial starch (1 g per kg body weight) was
done immediately after the administration of cyanidin-3-O-glucoside.
The doses are given on the graph. Plasma glucose was measured as
described in Materials and methods. Each value represents the mean ±
mean standard error of 3 mice.
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peak after 3 hours. After this peak the triglyceride concen-
tration declined slowly. After six hours it was close, but still
above, the concentration found at the administration time
(zero time). The experiments were repeated with mice to which
various doses of the jabuticaba peel extract or orlistat had
been administered. As expected, orlistat almost totally pre-
vented the rise in the plasma triglyceride concentration. The
various doses of the jabuticaba peel extract modified the
response in a concentration dependent manner. The lowest
dose (1 mg kg−1) accelerated the initial rise, but it also acceler-
ated the decline to values under those of the control curve at
4.5 hours. Extract doses from 5 to 250 mg kg−1 shifted the
response curve progressively in the direction of the curve
obtained with orlistat.
Fig. 10(B) shows the areas under the triglyceride curves sub-
tracted from the area under the curve obtained when orlistat
was given. This procedure normalizes the responses.
Administration of the jabuticaba peel extract produced a dose-
dependent decrease in the normalized area under the time-
response curves, suggesting inhibition of triglyceride absorp-
tion as the predominant effect. This is true even for the lowest
dose, which showed an initial increment above the control
curve. With the dose of 5 mg kg−1 the diminution of the nor-
malized area was equal to 67%. Numerical interpolation
revealed that 50% diminution can be expected at the dose of
3.65 mg kg−1.
Fig. 10(B) informs also, in addition to the peel extract
doses, the approximated doses of cyanidin-3-O-glucoside that
were automatically administered with the extract, calculated
using the content given in Table 1. Based solely on the data
obtained when the pancreatic lipase was measured, pure cyani-
din-3-O-glucoside doses in the range depicted in Fig. 10(B)
should not affect triglyceride absorption. Fig. 11 shows,
however, that this prediction was not confirmed. Two doses of
cyanidin-3-O-glucoside were administered, 0.2 and 2 mg kg−1.
The lower dose caused an initial increment in the concen-
tration of triglycerides after olive oil administration to mice,
Fig. 9 Blood glucose concentration profiles after intragastric glucose
loads in mice: the effect of the M. jaboticaba peel extract. The oral
administration of glucose (1.5 g per kg body weight) was done immedi-
ately after the administration of the extract. The doses are given on the
graph. Plasma glucose was measured as described in Materials and
methods. Each value represents the mean ± mean standard error of
4 mice.
Fig. 10 (A) Blood triglyceride concentration profiles after intragastric
olive oil loads in mice: the effect of the M. jaboticaba residues extract.
The oral administration of olive oil (5 mL kg−1) was done immediately
after the administration of the extracts or orlistat. The doses and their
estimated contents in cyanidin-3-O-glucoside are given on the graphs.
Plasma triglycerides were measured as described in Materials and
methods. Each value represents the mean ± mean standard error of
4 mice. (B) Areas under the curves obtained after the various treat-
ments with of M. jaboticaba extract illustrated by panel (A) subtracted
from the area under the curve obtained after orlistat administration.
Asterisks indicate statistical significance relative to the control curve
(p ≤ 0.05).
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similar to that found with the lowest jabuticaba peel extract
dose. After the peak at 1.5 h, however, there was a rapid
decline with a tendency of remaining under the control curve
during the subsequent 2 hours. The 2.0 mg kg−1 dose, on the
other hand, caused a clear diminution in the response. When
analyzed in terms of the normalized area under the curves, as
it was done with the response to the extract, a clear inhibition
of triglyceride absorption by the 2 mg kg−1 dose is apparent
(Fig. 11B). With the 0.2 mg kg−1 dose, however, a stimulatory
effect seems to predominate even though statistical signifi-
cance is lacking.
Effects on plasma triglycerides after oleic acid administration
The effects of cyanidin-3-O-glucoside on triglyceride absorp-
tion shown in Fig. 11, in principle at least, are difficult to
reconcile with its relatively weak action on the pancreatic
lipase in as much as very low doses were administered. It
could be that one or more steps of the overall absorption
process that are subsequent to the triglyceride hydrolysis step
are inhibited. This could involve free fatty acids. For this
reason, our approach to this question was to administrate free
oleic acid to mice with subsequent measurement of the trio-
lein equivalents in plasma. Table 2 shows the results obtained.
Data were expressed as the difference between the basal levels
and the levels found at 90 minutes after the administration of
oleic acid alone, glycerol alone and oleic acid + glycerol, with
or without previous administration of the peel extract or cyani-
din-3-O-glucoside. The assay of blood triglycerides that was
used in the present work actually measures the glycerol moiety
of these molecules. When glycerol was administered alone,
however, the assay system displayed a relatively small increase
(1.32-fold the basal value), which corresponds to 13% of the
increment that was found in the experiments where glycerol
and oleic acid were administered simultaneously (3.5-fold the
Fig. 11 (A) Plasma triglyceride concentration profiles after intragastric olive oil loads in mice: the effect of cyanidin-3-O-glucoside. The oral admin-
istration of olive oil (5 mL kg−1) was done immediately after the l administration of cyanidin-3-O-glucoside or orlistat. The doses are given on the
graphs. Plasma triglycerides were measured as described in Materials and methods. Each value represents the mean ± mean standard error of
3 mice. (B) Areas under the curves obtained after the various treatments with of M. jaboticaba extract illustrated by panel (A) subtracted from the
area under the curve obtained after orlistat administration. Asterisks indicate statistical significance relative to the control curve (p ≤ 0.05).
Table 2 Increments in plasma triolein equivalents per 100 mL due to oleic acid, glycerol and oleic acid + glycerol oral loads in mice. The basal con-
centration of triglycerides in this experimental series was 167.9 ± 7.7 mg triolein equivalents per dL (n = 23). The asterisks (*) indicate significant
difference (Student–Newman–Keuls test) with respect to the experiment group to which only oleic acid plus glycerol were administered. The










— — Oleic acid (180 μL) + glycerol (20 μL) 424.3 ± 28.8§ (n = 4)
5.0 — Oleic acid (180 μL) + glycerol (20 μL) 53.0 ± 27.0* (n = 4)
25.0 — Oleic acid (180 μL) + glycerol (20 μL) 66.8 ± 22.1* (n = 3)
— 0.2 Oleic acid (180 μL) + glycerol (20 μL) 74.3 ± 50.0* (n = 3)
— 2.0 Oleic acid (180 μL) + glycerol (20 μL) 43.0 ± 38.1* (n = 3)
— — Oleic acid (180 μL) 8.3 ± 2.3* (n = 3)
— — Glycerol (20 μL) 54.0 ± 10.8*,§ (n = 3)
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basal value). When oleic acid was given alone, no increase in
the concentration of triacylglycerols in blood was detected, pre-
sumably because one of the substrates (glycerol) needed for
synthesizing triglycerides was limiting. On the other hand, in
all mice that had received either peel extract or cyanidin-3-O-
glucoside previous to the glycerol + oleic acid administration,
the triglyceride assay system detected only small increments.
Actually, none of these increments was statistically different
from its corresponding basal value, as revealed by the paired
t-test. In statistical terms, thus, the effects of the extract and of
cyanidin-3-O-glucoside cannot be distinguished from each
other. It is worth mentioning that the peel extract doses of 5
and 25 mg kg−1 contained approximately 0.062 and 0.31 mg
kg−1 cyanidin-3-O-glucoside.
Discussion
Composition of the jabuticaba peel extract and general aspects
We have determined the phenolic profile of the extract used in
the present work instead of relying on literature data taking
into account that preparations of the kind may vary substan-
tially in their composition due to several factors. Regarding
the cyanidin-3-O-glucoside content, about 12.34 mg g−1 was
found in the extract. This value is less than that reported pre-
viously for a similar peel extract (±39.7 mg g−1 extract),5 but
higher than that one determined in jabuticaba pomace (±2 μg
g−1 extract).13 The variation in the content of anthocyanin
extracted from plant material can be a consequence of several
factors, ranging from the conditions of growth/maturation of
the plant, preparation of the sample, to the methods of extrac-
tion of these compounds from the plant tissue.5 Therefore, it
is important to note that the fruit ripening points in both
studies have not been determined, and distinct drying
methods were used (forced-air drying oven/freeze drying), as
well as different extraction methods.
Regarding the aims of the present work, two main intercon-
nected questions were formulated in the Introduction: (a) do
jabuticaba peel extracts affect starch and triacylglyceride
absorption? (b) if yes, what is the contribution of the impor-
tant component cyanidin-3-O-glucoside? The answer to the
first question is positive in that the peel extract clearly inhib-
ited both starch and triglyceride absorption, but the latter
effect was considerably stronger than the former. An answer to
the second question was equally found: cyanidin-3-O-glucoside
only minimally contributes to starch absorption inhibition by
the extract; it might eventually affect starch absorption at
doses that are well above those contained in the active extract
doses. The compound contributes in a decisive manner,
however, to the inhibitory effect of the extract on triglyceride
absorption, even though this contribution seems to occur pre-
dominantly via a mechanism that does not depend on the pan-
creatic lipase inhibition. Details and implications of each
action will be discussed separately in the following items. The
scheme in Fig. 12 illustrates the main points of our interpret-
ations and propositions.
Alpha-amylase activity and starch absorption
Inhibition of starch absorption by jabuticaba extracts and
anthocyanins in general has been claimed to represent a poss-
ible beneficial action of either the pure compounds or extracts
prepared in various ways.6,21 With respect to peel extracts,
however, it will be impossible to obtain specific inhibition of
starch absorption because inhibition of triglyceride absorption
occurs at much lower doses. As shown by our experiments,
5 mg kg−1 of the peel extract inhibited triglyceride absorption
to an extent that was similar to the inhibition of starch absorp-
tion caused by a 500 mg kg−1 dose. The difference comprises,
thus, two orders of magnitude. Our in vivo experiments are
also not in agreement with previous extrapolations based on
enzyme measurements which indicate that cyanidin-3-O-gluco-
side could be useful as an inhibitor of starch absorption.21,22
Fig. 12 Possible mechanisms of action and compounds in the jabuticba peel extract involved in the inhibition of starch and triglyceride absorption.
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The reason might be that the action of cyanidin-3-O-glucoside
as an inhibitor of α-amylase is not strong enough. In this par-
ticular respect our results are similar to those reported earlier.
In one study, for example, IC50 values of 0.393 and 0.450 mM
for the pancreatic and the salivary enzymes, respectively, were
found.21 Another study reported a IC50 of 0.3 mM for the pan-
creatic α-amylase and a IC50 >3 mM for the α-glucosidase.22
These numbers make one to expect that doses of at least
250 mg kg−1 of the compound are necessary for inhibiting
starch absorption in vivo. Such a dose is not realistic in terms
of the jabuticaba extract and even in pure form. It should also
be recalled that when mice were treated in our experiments
with realistic doses of cyanidin-3-O-glucoside (10 and 20 mg
kg−1), no inhibition of starch absorption was found. All these
observations indicate the participation of other substances.
The extract used in this work contains 28.5 mg g−1 non-antho-
cyanin polyphenolics. The IC50 for the extract as inhibitor of
the α-amylase is equal to 1.963 mg mL−1, what corresponds to
a total non-anthocyanin polyphenol concentration in the assay
system of 69.93 μM (summing up individually all compounds
and using their molecular weights). If the polyphenolics are
the main inhibitors, a reasonable hypothesis, the IC50 values
of the most important ones may be significantly smaller than
100 μM.23,24 For example, one of the components of the jabuti-
caba extract is pentagalloyl glucose for which we found, in pre-
vious work,23 inhibition constants of Ki1 = 78.5 (EI) and Ki2 =
36.4 μM (ESI). However, there are other compounds that might
be contributing. Tannins, for example, are present in the jabu-
ticaba fruit in relatively large proportions, and are also well
known inhibitors of α-amylases.16,25
Kinetic analysis of the results that were obtained in this
work revealed non-competitive inhibition and cumulative
binding of inhibitors leading to the formation of the EI, ESI
and EI2 complexes or even of higher orders (parabolic inhi-
bition). Eqn (2) that describes this mechanism is the same
that gave the best fit to the experimental data obtained with
pentagalloyl glucose.23 Equations of this kind are useful for
predicting the inhibition degree at any combination of sub-
strate and inhibitor concentrations. The heterogeneity of the
preparation that was used does not invalidate eqn (2), provided
that the proportions between the concentrations of the active
compounds are not modified, a condition that holds for
extracts with constant composition.26 The inhibition constants
resulting from the fitting procedure are complex functions of
several individual dissociation constants, but still a measure of
the strength of the preparation that was used in terms of its
mass.
Lipase activity and fat absorption
Inhibition of the pancreatic lipase by the jabuticaba peel
extract is of the parabolic type, at least with p-nitrophenyl-pal-
mitate as the substrate, meaning that it can accelerate as the
concentration is increased. Double binding by forming binary
(ESI2) or higher order enzyme–substrate–inhibitor complexes
seems to be the cause of the former phenomenon, as indicated
by the kinetic analysis. As already mentioned, the inhibitory
power of the extract on the pancreatic lipase was 13.6-fold
stronger than that on the pancreatic α-amylase. The partici-
pation of cyanidin-3-O-glucoside, however, is not very pro-
nounced. But, the extract contains several compounds that
may act as inhibitors, including several phenolics (see Table 1)
and tannins.16,25,27 Nonetheless, the potency of the extract
used in this work, which revealed an IC50 of 143.9 μg mL−1, is
not exceptional when compared to other preparations from
natural products. In a recent survey on formulations from
natural products with lipase inhibitor activities, 5 preparations
out of 13 are listed as having IC50 values smaller than 143.9 μg
mL−1.28 Based on the available experimental evidence, prep-
arations with IC50 values around 150 μg mL−1 would require
doses above 100 mg kg−1 in mice to produce significant inhi-
bition of triglyceride absorption. A preparation from the
pinhão coat (Araucaria angustifolia), rich in tannins, for
example, has an IC50 for the pancreatic lipase inhibition equal
to 240 μg mL−1 and the dose causing 50% inhibition of trigly-
ceride absorption is 258.9 mg kg−1.17 The jabuticaba peel
extract, however, inhibited triglyceride absorption at much
lower doses. Rigoroulsy, inhibition began with the 1 mg kg−1
dose and reached 65% with the 5 mg kg−1 dose. Taken
together, all these characteristics strongly suggest the existence
of at least one additional mechanism involved in the modifi-
cations in triglyceride absorption caused by the jabuticaba
peel extract. This interpretation is reinforced by the effect of
purified cyanidin-3-O-glucoside, which is a weak inhibitor of
the lipase, but a strong inhibitor of triglyceride absorption at a
dose that is consistent with its concentration in the peel
extract.
The existence of an alternative and concomitantly operating
mechanism is corroborated by the experiments in which free
oleate was administered to mice. It is since long known that a
free fatty acid load does not promote significant increases in
the concentration of nonesterified fatty acids in blood, so that
alternative procedures based on the endogenous release of free
fatty acids are utilized for evaluating free fatty acid tolerance.29
Changes in blood triglycerides, on the other hand, have been
since long regarded as a way of estimating free fatty acids
absorption.30,31 The assay procedure used in the present study
does not exclude interference by free glycerol, which can be
neglected in triacylglycerol tolerance tests because in this case
the administered triglycerides are anyway the only source of
the glycerol moiety. The data obtained in the experiments of
this work in which free oleic acid was administered can also
be regarded technically as an oleic acid-dependent absorption
of glycerol. However, based on the well-established notion that
the glycerol 3-phosphate pathway of triglycerides synthesis is
fully operative in enterocytes (in addition to the monoacyl gly-
cerol pathway)32 and the results of our control experiments, it
seems reasonable to assume that the transport of free glycerol
alone into plasma is severely limited and that it enters blood
mainly in the form of triacylglycerols after being co-absorbed
with oleic acid. In this respect it can be considered quite sig-
nificant that both cyanidin-3-O-glucoside and the peel extract
strongly inhibited the glycerol dependent co-absorption of
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oleic acid, a phenomenon that occurred with doses of cyani-
din-3-O-glucoside that are consistent with its concentration in
the extract. The bulk of the observations strongly suggest that
the inhibitory effect of low doses of the jabuticaba extract may
occur with a significant if not predominating contribution of
cyanidin-3-O-glucoside.
Inhibition of triglyceride absorption by mechanisms that
are concomitant or even independent of the inhibition of
lipases have already been suggested by several studies. Even
for orlistat, the classical inhibitor of triglyceride absorption,
inhibition of fatty acyl synthase is now accepted as an
additional action that superimposes on the lipase inhibitory
activity.33 The mechanism by which cyanidin-3-O-glucoside
acts cannot be deduced from the results of this work. The
overall process of fatty acid absorption and subsequent release
as triglycerides is actually fairly complex and consists in
various steps involving several enzymes and proteic
factors.34–36 Full clarification of the action of cyanidin-3-O-glu-
coside or that of other compounds in the jabuticaba peel
extract will certainly require exhaustive and specific experimen-
tation. Hypotheses, however, can be formulated. Cyanidin-3-O-
glucoside could be acting on the transport of free fatty acids
across the enterocyte membrane or it could be inhibiting one
or more post-absorption metabolic steps in the process of tri-
glyceride synthesis as illustrated by Fig. 12. Inhibition of gly-
cerol transport from the lumen into the enterocyte is much
less likely it one takes into account that cyanidin-3-O-glucoside
also inhibited the absorption of triglycerides, a process in
which monoacyl-glycerol is the main glycerol source. It is pre-
sently accepted that free fatty acids, in spite of their lipophilic
nature, have their movements across the cell membrane and
across the cellular compartments greatly facilitated when
bound to specific proteins. Up to now three classes of fatty
acid transport proteins have been described: the fatty acid
binding protein (FABP), the fatty acid translocase (FAT, also
known as scavenger receptor CD36), and the family of fatty
acid transport proteins (FATP1-6).36–38 It has also been
suggested that some of these proteins might be arranged in a
complex within the cell membrane, for example the FAT plus
FATP in addition to the very-long chain acyl CoA synthase, in
order to promote a more effective transportation of free fatty
acids through the cell membrane coupled to their transform-
ation along the cell space in direction to the sites where incor-
poration into supramolecular structures occurs.37,38 Inhibitors
of these transport proteins have already been identified, most
of them of plant origin. Lipofermat, for example, inhibits free
fatty acid transport in several cell types, including intestinal
epithelial cells.36,39 Consistently, it has been shown that this
compound also inhibits, in a dose-dependent manner, the
incorporation of orally administered [13C]oleate into plasma
lipids in mice.39 Lipofermat and cyanidin-3-O-glucose are
different molecules having in common, however, aromatic
rings in their structures, which should facilitate their inter-
actions with the lipophilic environment that fatty acids require
for transportation, diffusion and transformation. The results
obtained in this study allow to suggest, thus, that cyanidin-3-
O-glucose might be an inhibitor of free fatty acid transport.
Alternatively, it is equally possible that cyanidin-3-O-glucose
acts by inhibiting one or more steps in the metabolic trans-
formations that lead to the transformation of free fatty acids
into triglycerides via both the monoacylglycerol or glycerol
3-phoshate pathways,32 especially if one considers that these
transformations occur in a complex lipidic environment. Only
specific experimentation will allow to decide among these two
possibilities. Experimentation must also take into account the
observation of a higher plasma triglyceride concentration at
90 minutes following the olive oil load when the lowest extract
and cyanidin-3-O-glucoside doses were administered (Fig. 10
(A) and 11(A)). The curves decline strongly afterwards, but they
may be revealing a fast-stimulatory action that superimposes
on the inhibitory action that predominates later in time and is
the only effect that can be seen at higher doses. It should be
stressed that this phenomenon was observed with both pure
cyanidin-3-O-glucose and the peel extract. This observation
actually denotes a highly complex action mechanism for cyani-
din-3-O-glucoside and possibly other components of the jabu-
ticaba peel extract, a characteristic that will certainly stimulate
future work on the subject.
Conclusion
It can be concluded that the jabuticaba peel extract presents
many favourable perspectives as an inhibitor of fat absorption
and that cyanidin-3-O-glucoside, one of its main constituents,
seems to play a decisive role. Application of the peel extract or
even pure cyanidin-3-O-glucoside as weight reducing pharma-
cological agents and diets for treating obesity seems to be a
real possibility. A fundamentally important characteristic of
the jabuticaba peel extract is the low doses that are required to
reduce fat absorption. This requirement extends also to the
component cyanidin-3-O-glucoside. However, in practical
terms, the preparation of an effective jabuticaba peel extract is
much easier and cheaper in contrast to cyanidin-3-O-glucoside,
whose isolation in pure form seems to be quite expensive, at
least at the present stage. Moreover, as it has been investigated
by our team, jabuticaba peel extracts also have potential for
being used as natural colorants in the food industry.40 Thus,
the combination of these functionalities, enhances the interest
in its exploration as a source of high added-value ingredient
for the production of functional foods. Furthermore, the jabu-
ticaba skins are usually discarded during industrial processing
of the fruit, a fact that generates abundant and cheap feed-
stock for semi-purified pharmaceutical formulations and food
additives. In such a context further mechanistic and perhaps
clinical studies are certainly highly desirable.
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